Related Experiment Video
Updated: Mar 6, 2026

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
4.0K
[Molecular-allergological aspects of allergen-specific immunotherapy]
Uta Jappe1,2
1Forschungsgruppe Klinische und Molekulare Allergologie, Forschungszentrum Borstel, Parkallee 35, 23845, Borstel, Deutschland. ujappe@fz-borstel.de.
Summary
Allergen-specific immunotherapy (SIT) has limitations in efficacy and predicting failure. Molecular phenotyping offers improved patient characterization by identifying key allergens and predicting treatment outcomes.
Area of Science:
- Allergy and Immunology
- Molecular Diagnostics
Background:
- Allergen-specific immunotherapy (SIT) is a crucial treatment for allergic diseases but lacks consistent efficacy and reliable failure markers.
- Current diagnostic approaches do not fully capture the complexity of patient sensitization.
Purpose of the Study:
- To highlight advances in molecular allergology for improved patient phenotyping in SIT.
- To identify key allergens that predict disease severity and treatment response.
Main Methods:
- Utilizing molecular-allergological analysis methods for detailed patient characterization.
- Employing molecular phenotyping to identify major and minor allergens.
Main Results:
- Identification of specific marker allergens associated with allergic reaction severity.
- Determination of allergens that predict pathological and therapeutic outcomes.
- Comprehensive mapping of patient sensitization patterns.
Conclusions:
- Molecular phenotyping significantly enhances patient characterization for SIT.
- This approach provides predictive markers for treatment success and disease severity.
- Advances in molecular allergology offer a path towards more personalized and effective immunotherapy.
Related Concept Videos
Allergic Reactions
33.1K
Overview
33.1K
Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Allergic Reactions: Anaphylaxis
92
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
92
Drug Toxicity: Allergic Reactions
80
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
80
Antigens Involved in Adaptive Immunity
1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Cross-reactivity
33.6K
Overview
33.6K

